Honorary Chairs

Daniel brings over two decades of experience in the biotechnology / pharmaceutical sectors, with the past 15 years as an investor, focusing on “tomorrow’s cures” for today’s critical medical needs. His investments span the entire lifecycle of biotech companies, from initial Series A funding to advanced venture rounds, crossover financings, IPOs, and a diverse range of public market strategies, including follow-on offerings, private investments in public equity (PIPEs), and reverse mergers. Throughout his career, Mr. Krizek has financed over 100 private biotech companies, and served on dozens of Boards as an observer.

Currently, Mr Krizek is a Portfolio Manager at Citadel’s Surveyor Capital, where he oversees one of the largest biotech investment portfolios in the world. Prior to Citadel, he held the position of Director at Bain Capital, managing private and public biotech investments. Earlier in his career, Mr. Krizek worked as a consultant at McKinsey & Company, where he advised leading clients in pharmaceutical, biotech, and med-tech industries.

He is a graduate of Stanford University, and a holder of CFA (Chartered Financial Analyst) and CAIA (Chartered Alternative Investment Analyst) designations. When not attending scientific conferences around the world, he resides in Miami.